Bionano Genomics, Inc. — Director's Dealing 2021

Apr 23, 2021

SEC Form 3/A — Form 3/A

Issuer: Bionano Genomics, Inc (BNGO)
CIK: 0001411690
Period of Report: 2020-08-31

Reporting Person: Chaubey Alka (Chief Medical Officer)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (right to buy)	$0.50	2030-07-14	Common Stock (10000)		Direct
Stock Option (right to buy)	$4.03	2029-04-30	Common Stock (5000)		Direct
Stock Option (right to buy)	$7.77	2028-09-30	Common Stock (10210)		Direct

Footnotes

F1: The shares vest in 48 equal monthly installments from July 15, 2020, such that the option shall be fully vested and exercisable on the four-year anniversary of such date.

F2: The shares vest in 48 equal monthly installments from May 1, 2019, such that the option shall be fully vested and exercisable on the four-year anniversary of such date.

F3: 25% of the shares vested on October 1, 2019, and the remaining shares vest in 36 equal monthly installments thereafter.